| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.3 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.3 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.3 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.3 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.047 | 0.3 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.3 |